School of Medicine
Showing 1,101-1,180 of 1,180 Results
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Julia Weinman
Affiliate, Psych/General Psychiatry and Psychology (Adult)
BioJulia Weinman, MS, MA is a doctoral research affiliate within the Department of Psychiatry and Psychology at the Stanford School of Medicine in the Neuropsychology, Mood and Anxiety Disorder, and Women's Mental Health Lab. She is a doctoral candidate, pursuing her PhD in clinical psychology at Palo Alto University. Her research focuses on interpersonal trauma, empowerment, and post-traumatic growth. Currently, she is working with Dr. Jennifer Keller on the Building Empowerment and Resilience (BEAR) program for adult women with histories of interpersonal trauma.
-
Aileen Whyte
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders. -
Bo Dehm Wicklund
Affiliate, Psych/Public Mental Health & Population Sciences
BioClinical Research Coordinator- NEAT Lab (Dr. Michelle R. Madore)
University of Connecticut
B.A. Psychology, Minor Cognitive Science -
Leanne Williams
Vincent V.C. Woo Professor and Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)
BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award and Colvin Prize). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise on the effects of trauma across the lifespan. She provides clinical services for children, adolescents, adults, and families affected by trauma and other forms of anxiety and stress. Dr. Wilson also leads an active research program focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood. She is the Principal Investigator of GIRLTALK: We Talk, a longitudinal study funded by the National Institute of Child Health and Human Development (NICHD) that examines links from childhood violence exposure to dating violence and sexual risk in young women from low-income communities in Chicago. Dr. Wilson has authored or co-authored thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is on the editorial board of the Journal of Youth and Adolescence.
-
Shannon Wiltsey Stirman
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.
-
Britt Wray
Instructor, Psychiatry and Behavioral Sciences
BioDr. Wray is the Director of CIRCLE at Stanford Psychiatry, a research and action initiative focused on Community-minded Interventions for Resilience, Climate Leadership and Emotional wellbeing in the Stanford School of Medicine. Before this she was a Human and Planetary Health Postdoctoral Fellow at the Stanford Center for Innovation in Global Health, Stanford Woods Institute for the Environment and London School of Hygiene & Tropical Medicine. Her research focuses on the mental health impacts of climate change on young people ('emerging adults') and frontline community members, community-minded psychosocial support interventions, and public engagement for improved mental and planetary health. She is the author of two books; her latest Generation Dread: Finding Purpose in an Age of Climate Anxiety, is an impassioned generational perspective on how to stay sane amid climate disruption and was a finalist for the 2022 Governor General’s Award. She is the recipient of the 2023 Canadian Eco-Hero Award and top award winner of the National Academies Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by The National Academies of Sciences, Engineering, and Medicine. Her first book is Rise of the Necrofauna: The Science, Ethics and Risks of De-Extinction (Greystone Books 2017) and was named a "best book of the year" by The New Yorker. Dr Wray holds a PhD in Science Communication from the University of Copenhagen. She has hosted and produced several science radio programs, podcasts and television programs for international broadcasters including the BBC and CBC, and she has spoken at TED and the World Economic Forum. She is the Founder of Gen Dread (gendread.substack.com), a newsletter about building courage and taking meaningful action on the far side of climate grief.
-
Yishan Xu, PhD, DBSM, CST
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Xu is a licensed clinical psychologist in California, a Board-certified Behavioral Sleep Medicine Specialist, and AASECT Board-Certified Sex Therapist. She currently serves as the chair of the OPEC committee for the Society of Behavioral Sleep Medicine. She completed training at the Stanford Sleep Medicine Center 2017-2019. She has specialized training in the diagnosis and treatment of insomnia, circadian rhythm disorders, parasomnias, nightmares, and adjustment to PAP therapy for sleep apnea.
Dr. Xu grew up in China and received her Ph.D. in Clinical Psychology from the University of Virginia, VA. She has adapted treatment for insomnia for the Chinese population, and translated the book “The Rested Child” into Chinese, which is the first evidence-based book about children and teen’s sleep disorders in China. She is the founder and director of a multicultural group practice in the SF Bay Area: Mind & Body Garden Psychology Inc. She also hosts a podcast "Deep into Sleep" to help bridge the gap between public awareness and knowledge of sleep problems and the science of sleep medicine.
Publications:
Xu, Y., Barwick, F. & Li, C.(2023). Cultural Considerations in Behavioral Sleep Medicine (BSM): Telehealth Group CBT-I for Patients from a Traditional Chinese Medicine (TCM) Hospital (Submitted)
Prislin, R., Davenport, C., Xu, Y., Moreno, R., & Honeycutt, N. (2018). From marginal to mainstream and vice versa: Leaders' evaluation of diversity while in the minority versus majority. Journal of Social Issues, 74 (1), 112-128.
Attin, M., Xu, Y., Lin, C. D., & Lemus, H. (2015). A potential impact of nursing characteristics prior to in-hospital cardiac arrest: a self-reported study. Journal of Clinical Nursing, 24 (23-24), 3736-3738.
Hu, Y., Xu, Y.,& Tornello, S. L. (2015). Stability of Self-Reported Same-Sex and Both-Sex Attraction from Adolescence to Young Adulthood. Archives of sexual behavior, 1- 9.
Xu, Y., & Ocker, B. (2013). Discrepancies in Cross-cultural and cross-generational attitudes toward committed relationships in China and the United States. Family Court Review, 51 (4), 591–604.
Tornello, S. L., Emery, R., Rowen, J., Potter, D., Ocker, B., & Xu, Y. (2013). Overnight custody arrangements, attachment, and adjustment among very young children. Journal of Marriage and Family, 75 (4), 871-885.
Horn, E. E., Xu, Y., Beam, C. R., Turkheimer, E. & Emery, E. (2012). The marriage benefit? A genetically-informed study of selection and causation. Journal of Family Psychology, 27 (1), 30-41.
Prislin, R., Boyle, S. M., Davenport, C., Farley, A., Jacobs, E., Michalak, J., Uehara, K., Zandian, F., & Xu. Y. (2011). On being influenced while trying to persuade: The feedback effect of persuasion outcomes on the persuader. Social Psychological and Personality Science, 2 (1), 51-58.
Li, j., Xu, Y., & li, X. (2009). Correlation between atypical eating disorder and body- esteem of college students. Chinese Journal of Clinical Psychology, 17, 345-347. -
Xiao Yang
Postdoctoral Scholar, Psychiatry
BioXiao Yang is a Wu Tsai Neurosciences Institute Interdisciplinary Postdoctoral Scholar at Stanford University, working jointly in the laboratories of Professor Sergiu P. Pașca (Psychiatry and Behavioral Sciences) and Professor Bianxiao Cui (Chemistry). She received her Ph.D. in Chemistry from Harvard University under the guidance of Professor Charles M. Lieber in 2020, and her B.S. in Chemistry from the College of Chemistry and Molecular Engineering at Peking University in 2015.
Dr. Yang will join the Department of Biomedical Engineering at Johns Hopkins University as an Assistant Professor in June 2025.
Dr. Yang drew inspiration from biological systems and art forms to design and develop a series of bio-inspired and art-inspired bioelectronics. Her studies encompass neural probes for in vivo brain-machine interface, electronic scaffolds for brain repair, and platforms for detecting human genetic diseases and tracking human neural development using human brain organoids.
Bioelectronic devices are important as fundamental research tools for probing and understanding the brain with high spatiotemporal resolution, and as potential therapeutic avenues for treating brain diseases, disorders, and injuries. However, they face key challenges, such as achieving biomimicry at the molecular level, expanded multifunctionality at the microscale, and versatile programmability at the macroscale. The Yang Lab will address these challenges by integrating bioelectronics, bioengineering, chemistry, materials science, and neuroscience. We aim to develop novel bioelectronics and biomaterials for brain-machine interfaces, regenerative medicine, and the study of human neural development and diseases. -
Jerome Yesavage
Jared and Mae Tinklenberg Professor and Professor, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsWe study cognitive processes and aging in our research center. Studies range from molecular biology to neuropsychology of cognitive processes.
-
Audrey Yoon, DDS
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Yoon is a double board-certified sleep specialist with the Stanford Health Care Sleep Medicine Center. She is currently a Clinical Professor in the Division of Sleep Medicine in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
She uses her extensive orthodontic experience to diagnose and treat obstructive sleep apnea (OSA) in children and adults. Dr. Yoon specializes in surgical and non-surgical OSA treatments, such as miniscrew-assisted rapid palatal expansion (MARPE), distraction osteogenesis maxillary expansion (DOME), and maxillomandibular advancement (MMA). These procedures restructure the palate, nasal airway, or jaw to improve airflow.
Her research interests include modifying head and face growth to improve sleep-disordered breathing in children and creating customized appliances that help reshape bones in the mouth, jaw, and face over time. She has also studied genetic anatomical factors related to OSA. Dr. Yoon worked with Stanford Medicine researchers to develop a new DOME technique, and she established and proposed a surgery-first approach protocol for MMA. With this approach, doctors surgically reposition the jaw before starting orthodontic treatment. The surgery-first approach can reduce the amount of time patients need to undergo orthodontic treatment.
Dr. Yoon has published in many peer-reviewed journals, including Sleep, Sleep Medicine, the American Journal of Orthodontics and Dentofacial Orthopedics, and the American Academy of Pediatric Dentistry, and she has written numerous book chapters. She has presented to her colleagues all over the nation and the world, including those in Germany, Italy, Australia, Chile, Singapore and China. Her presentations have covered a range of topics, such as the latest techniques in craniofacial (head and face) growth modification.
Dr. Yoon is a founding co-president of the World Dentofacial Sleep Society. She established a dental sleep medicine specialty clinic in the Division of Sleep Medicine at Stanford University School of Medicine. She also established the Dental Sleep Medicine Clinic at the University of the Pacific and is currently a program director of the Pacific Ortho-Dental Sleep Medicine Fellowship Program. Dr. Yoon also serves on the board of directors for the California Sleep Society, Angle Orthodontists, and the Korean Association of Dental Sleep Medicine.
She is a diplomate of the American Board of Orthodontics and the American Board of Dental Sleep Medicine. -
Jong H. Yoon
Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMy research seeks to discover the brain mechanisms responsible for schizophrenia and to translate this knowledge into the clinic to improve how we diagnose and treat this condition. Towards these ends, our group has been developing cutting-edge neuroimaging tools to identify neurobiological abnormalities and test novel systems-level disease models of psychosis and schizophrenia directly in individuals with these conditions.
We have been particularly interested in the role of neocortical-basal ganglia circuit dysfunction. A working hypothesis is that some of the core symptoms of schizophrenia are attributable to impairments in neocortical function that results in disconnectivity with components of the basal ganglia and dysregulation of their activity. The Yoon Lab has developed new high-resolution functional magnetic resonance imaging methods to more precisely measure the function of basal ganglia components, which given their small size and location deep within the brain has been challenging. This includes ways to measure the activity of nuclei that store and control the release of dopamine throughout the brain, a neurochemical that is one of the most important factors in the production of psychosis in schizophrenia and other neuropsychiatric conditions. -
Kei Yoshimatsu
Clinical Instructor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioKei Yoshimatsu, MD, is an adjunct clinical faculty member within the Department of Psychiatry and Behavioral Sciences. His clinical interests include community and public psychiatry, homeless mental health, as well as LGBTQ mental health. He has completed his residency and fellowship at University of California, San Francisco.
-
Sanno Zack
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Zack is involved with ongoing research related to the treatment of adolescent and adult trauma (Trauma Focused Cognitive Behavioral Therapy - TF-CBT; Prolonged Exposure - PE), and the effective provision of Dialectical Behavior Therapy (DBT) to adolescent girls and women with disorder of emotion regulation. She additionally studies Acceptance and Commitment Therapy (ACT) for adolescent girls with anxiety. More broadly she is interested in the impact of Evidenced Based Treatments on improving quality of life, and helping individuals find the right match for clinical care. Research is conducted through the Early Life Stress and Pediatric Anxiety Disorders Program at Stanford Children's Hospital and the Stanford Dialectical Behavior Therapy Program.
-
Natalie M. Zahr
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Major Laboratories)
BioNatalie M. Zahr received a graduate education in the basic sciences including the study of neuro- pharmacology, physiology, and anatomy. After completing her graduate training in electrophysiology, she began a postdoctoral fellowship as a magnetic resonance imaging (MRI) scientist. Her work focuses on translational approaches using in vivo MR imaging and spectroscopy in studies of human with Alcohol Use Disorders (AUD) and in rodent models of alcohol exposure with the goal of identifying mechanisms of alcohol effects on the brain. Her human studies include participants with HIV, those co-morbid for HIV and AUD and recently, aging individuals with mild cognitive impairment (MCI). Her position allows her to explore emerging MR technologies and apply them to test relevant hypotheses. Before joining Stanford, she taught at several local institutions including UC Berkeley extension and Santa Clara University where she enjoyed sharing her knowledge and enthusiasm for learning with students.
-
Isheeta Zalpuri
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Isheeta Zalpuri is a child, adolescent and adult psychiatrist. She specializes in the treatment of pediatric anxiety and mood disorders.
Dr. Zalpuri has a special interest in faculty development, professional development of trainees, physician well-being and cultural psychiatry. -
Mira Zein
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Zein received her dual bachelor’s degrees in Anthropology and Physiological Science at UCLA and worked initially as a healthcare consultant, developing programs that improve healthcare access for vulnerable populations. She returned to school to pursue a Masters in Public Health at Johns Hopkins University; her research foci were disaster response interventions for physical and mental health and the impact of the built environment on public health. During her masters, she worked with the International Rescue Committee in Baltimore to help address the acculturation and psychological stress the Baltimore refugee population faced in resettlement.
Dr. Zein completed her medical training at McGill University. During medical school she continue to pursue interests in global and cultural health, focusing on national and local clinical projects to support refugee and asylum seeker access to medical and mental health treatment as part of CFMS. She was awarded the Mona Bronfman Sheckman Prize in Psychiatry for her work. During her psychiatry residency training at New York University (NYU), Dr. Zein continued pursuing her interest in global mental health, working as a group leader for refugees/asylum seekers in the Bellevue Survivors of Torture program, and the Association for Culture and Psychiatry.
She also became interested in models of Integrated Behavioral Health (IBH) to provide better access to mental health services within primary care and other settings. She founded the Integrated Behavioral Health resident working group and designed a two-year resident training program in the Collaborative Care Model, and developed a Collaborative Care model in one of NYU Langone-Brooklyn's FQHC sites. She completed residency as a chief resident and won awards for Excellence in Resident Teaching as well as for humanism and clinical excellence in the Comprehensive Psychiatric Emergency Program
Dr. Zein completed her Consult Liaison Fellowship at Stanford and has remained as clinical faculty. She previously currently served as an attending psychiatrist on the General, Intensive Care, and ED-Psychiatry Consult service. She currently works as the Psychiatric Director for Integrated Behavioral Health. She initially the model for the Stanford Primary Care Clinic serving Cisco employees and their families. She is currently working on expanding Integrated Behavioral health to other Stanford Primary Care Clinics, and has worked with Stanford's Digital Health Team to start and expand psychiatry e-consults for primary care. She also works as the Behavioral Health Director for Cisco, applying principles of organizational psychiatry and public health to assess company behavioral health strategy and provide support for Cisco employees and their families. Additionally, Dr Zein is part of the Stanford Mental Health lab where she supervises and completes evaluations for refugee and asylum seekers, and teaches Neuroscience and Psychopharmacology for the Psychiatry Residents -
Jamie Zeitzer
Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders. -
Wendy Zhang
Postdoctoral Scholar, Psychiatry
BioWendy Zhang, Ph.D. (she/her) is a clinical psychology postdoctoral fellow in the INSPIRE Clinic at the Department of Psychiatry and Behavioral Sciences. Clinically, Dr. Zhang specializes in evidence-based assessment and therapeutic intervention for individuals experiencing psychosis and their families. Dr. Zhang provides clinical care through a culturally-informed and recovery-oriented lens in both English and Mandarin Chinese. Dr. Zhang's current research focuses on early detection of psychosis risk and dissemination strategies for evidence-based treatment, including cognitive behavioral therapy for psychosis (CBTp), to improve early psychosis care.
-
Xue Zhang
Postdoctoral Scholar, Psychiatry
BioDr. Zhang received her PhD degree in 2019 in Biomedical Engineering from Tsinghua University School of Medicine. She was a Visiting Student Researcher in the Radiology Department at Stanford in 2017-2018. Her PhD research involved methods development for dynamic fMRI and concurrent fPET-fMRI and its application in identifying neuroimaging markers for depression vulnerability. As a postdoc in Williams PanLab, Dr. Zhang’s research interest lies at the intersection of neuroimaging and computation, and their translation in addressing clinical questions in psychiatry. Currently, Dr. Zhang is interested in how the acute experience under ketamin, MDMA, and psilocybin modulates brain activity changes under resting-state and task-evoked states and its relevance to their therapeutic effect.
-
Yuan Zhang
Basic Life Research Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordBasic Life Research Scientist
-
Sa Zhou
Postdoctoral Scholar, Psychiatry
BioSa Zhou completed her Ph.D. in Biomedical Engineering at The Hong Kong Polytechnic University, under the supervision of Dr. Xiaoling Hu and Prof. Yongping Zheng. Her Ph.D. research focused on quantitative evaluation and targeted therapeutics for sensory-motor rehabilitation in stroke patients. She developed strong interests in developing closed-loop brain-computer interface (BCI)-driven neuromodulation and robotic systems, designing neuro-behavioral measurements, and understanding functional connectivity in brain networks based on multimodal neurophysiological signals. At Stanford, Sa will contribute her interdisciplinary expertise to the field of cognitive enhancement to prevent cognitive decline and brain aging in the elderly at risk for Alzheimer’s disease (AD) or AD related dementia (AD/ADRD). Outside of the lab, you can find Sa engaging in strength training deadlifting/squatting/running in the gym to enhance her own sensory/motor/cognitive functions.
-
Lindsey Zimmerman
Affiliate, Psych/Public Mental Health & Population Sciences
BioLindsey Zimmerman, PhD, is a Clinical and Community Psychologist, and Implementation Scientist at the National Center for PTSD, Dissemination and Training Division of the Veterans Health Administration.
Dr. Zimmerman is principal investigator of National Institutes of Health (NIH) and Veterans Health Administration (VA) research that enlists participatory system dynamics to increase timely patient access to evidence-based pharmacotherapy and evidence-based psychotherapy for depression, PTSD, alcohol and opioid use disorder. See https://mtl.how/team
Active NIH Grants
Participatory System Dynamics vs Audit and Feedback: A Cluster Randomized Trial of Mechanisms Of Implementation Change to Expand Reach of Evidence-Based Addiction and Mental Health Care (R01DA046651)
The most common reasons Veterans seek VA addiction and mental health care is for help with opioid and alcohol misuse, depression and PTSD. Research evidence has established highly effective treatments that prevent relapse, overdose and suicide, but even with policy mandates, performance metrics, and electronic health records to fix the problem, these treatments may only reach 3-28% of patients. This study tests participatory business engineering methods to better meet the addiction and mental health needs of Veterans and the U.S. population.
Participatory System Dynamics for Evidence-Based Addiction and Mental Healthcare (R21DA042198)
Limited access and delays to high-quality, evidence-based mental health and addiction treatments can lead to patients getting too little or ineffective care and contribute to chronic patient impairment, relapse, and death by suicide or overdose. This study evaluates a system for resolving problems with patient flow and organization in health care systems, using electronic medical record systems and a high-level of input from healthcare leadership, frontline providers and patients.
Active VA Grants
Participatory System Dynamics vs Usual Quality Improvement: Is Staff Use of Simulation an Effective, Scalable and Affordable Way to Improve Timely Veteran Access to High-quality Mental Health Care? (I01HX002521)
Participatory system dynamics (PSD) helps improve quality with existing resources, critical in mental health and all VA health care. PSD uses learning simulations to improve staff decisions, showing how goals for quality can best be achieved given local resources and constraints. We aim to significantly increase the proportion of patients who start and complete evidence-based care, and determine the costs of using PSD for improvement.
National Responsibilities
2019 National Institutes of Health, Center for Scientific Review
Community Influences on Health Behavior (CIHB) Study Section
2019-present VA Quality Enhancement Research Initiative (QUERI)
QUERI/Health Services Research & Development, Scientific Merit Review Committee
2019-present Emory University
Prolonged Exposure Consultant Training Program Advisory Board
2018-present National Institutes of Health
Training Institute for Dissemination and Implementation Research in Health (TIDIRH)
Mental Health Faculty Mentor
2015-2017 National Institutes of Health Loan Repayment Program
National Institute of Mental Health Clinical Research Review Committee
Teaching Responsibilities
Quality Improvement and Systems of Care Competencies
Psychiatry & Behavioral Sciences Residency, Stanford University School of Medicine & VA Palo Alto Health Care System
Postdoctoral Research Fellowship Program Seminar
VA Palo Alto research centers of the National Center for PTSD (NCPTSD), Center for Innovation to Implementation (Ci2i), Mental Illness Research Education and Clinical Care (MIRECC), and War-related Illness and Injury Study Center (WRIISC).
Open Science Resources for the Modeling to Learn Simulation Learning Program are available on GitHub at https://mtl.how and https://mtl.how/demo
